Cardlytics (CDLX) Stock Forecast & Price Target

$3.80

+0.10 (+2.70%)

(As of 09/18/2024 ET)

Cardlytics - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Reduce
Based on 6 Analyst Ratings

Based on 6 Wall Street analysts who have issued ratings for Cardlytics in the last 12 months, the stock has a consensus rating of "Reduce." Out of the 6 analysts, 1 has given a sell rating, and 5 have given a hold rating for CDLX.

Consensus Price Target

$7.50
97.37% Upside

High Forecast	$12.00
Average Forecast	$7.50
Low Forecast	$3.50

According to the 6 analysts' twelve-month price targets for Cardlytics, the average price target is $7.50. The highest price target for CDLX is $12.00, while the lowest price target for CDLX is $3.50. The average price target represents a forecasted upside of 97.37% from the current price of $3.80.

Type	Current Forecast 9/20/23 to 9/19/24	1 Month Ago 8/21/23 to 8/20/24	3 Months Ago 6/22/23 to 6/21/24	1 Year Ago 9/20/22 to 9/20/23
Consensus Rating	Reduce	Reduce	Moderate Buy	Hold
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	0 Buy rating(s)	0 Buy rating(s)	4 Buy rating(s)	1 Buy rating(s)
Hold	5 Hold rating(s)	5 Hold rating(s)	2 Hold rating(s)	1 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$7.50	$7.50	$12.67	$10.50
Forecasted Upside	97.37% Upside	29.95% Upside	26.19% Upside	2.35% Upside

Biden’s Capital Gains Tax to Devastate Savings! (Ad)

Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.

>> Get Your FREE Wealth Protection Guide <<

CDLX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CDLX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Cardlytics Stock vs. The Competition

Type	Cardlytics	Business Services Companies	S&P 500
Consensus Rating Score	1.83	2.66	2.50
Consensus Rating	Reduce	Moderate Buy	Moderate Buy
Predicted Upside	97.37% Upside	266.18% Upside	7.94% Upside
News Sentiment Rating	Neutral News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
8/16/2024	Northland Capmk 0 of 5 stars	L. Horton Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/16/2024	Northland Securities 4 of 5 stars		Downgrade	Outperform ➝ Market Perform	$7.00 ➝ $5.00	+33.33%
8/15/2024	Bank of America 4 of 5 stars		Downgrade	Neutral ➝ Underperform	$4.00 ➝ $3.50	-5.15%
8/8/2024	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Kreyer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold
8/8/2024	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Stephan Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold	$18.00 ➝ $5.00	-27.54%
8/8/2024	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Peterson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold
Biden's Successor: The Radical Threat to YOUR Savings! (Ad) Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL. >> Get Your FREE Wealth Protection Guide <<
8/2/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$6.00 ➝ $9.00	-33.23%
4/12/2023	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Underweight	$5.00 ➝ $6.00

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 05:15 AM ET.

CDLX Forecast - Frequently Asked Questions

What is Cardlytics' forecast for 2024?: According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Cardlytics is $7.50, with a high forecast of $12.00 and a low forecast of $3.50.
Should I buy or sell Cardlytics stock right now?: 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardlytics in the last year. There is currently 1 sell rating and 5 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "reduce" CDLX shares.
Does Cardlytics's stock price have much upside?: According to analysts, Cardlytics's stock has a predicted upside of 29.95% based on their 12-month stock forecasts.
Has Cardlytics been downgraded by Wall Street analysts recently?: Over the previous 90 days, Cardlytics's stock had 6 downgrades by analysts.
What analysts cover Cardlytics?: Cardlytics has been rated by research analysts at Bank of America, Craig Hallum, Lake Street Capital, Needham & Company LLC, Northland Capmk, and Northland Securities in the past 90 days.
Do Wall Street analysts like Cardlytics more than its competitors?: Analysts like Cardlytics less than other "business services" companies. The consensus rating for Cardlytics is Reduce while the average consensus rating for "business services" companies is Moderate Buy. Learn more on how CDLX compares to other companies.